ProCE Banner Activity

Evidence-Based Guidance on New Paradigms in the Treatment of Acute Myeloid Leukemia


Download this slideset for expert perspectives on best practices for managing AML in patients with and without actionable biomarkers, including a discussion on optimal maintenance strategies

Released: August 15, 2023



Daniel A. Pollyea

Daniel A. Pollyea, MD, MS

Professor of Medicine
Clinical Director of Leukemia Services
Associate Chief of Clinical Affairs
Robert H. Allen MD Chair in Hematology Research
Division of Hematology
University of Colorado School of Medicine
Aurora, Colorado

Provided by

Provided by the National Comprehensive Cancer Network in partnership with Clinical Care Options, LLC

ProCE Banner
ProCE Banner


Supported by an independent educational grant from AbbVie Inc.

AbbVie Inc.